Inventor
Rima Kaddurah-Daouk
Inventor
Belmont, MA, US
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties25%
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
Y02ATechnologies for adaptation to climate change13%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
C07DHeterocyclic compounds5%
C07KPeptides4%
C12NMicroorganisms or enzymes4%
C12YEnzymes4%
A61QSpecific use of cosmetics or similar toiletry preparations3%
PatentTitleYear
8,637,321'Lipidomics approaches for central nervous system disorders'20148,394,354'Biomarkers for depression and methods using the same'20138,137,977'Lipidomic approaches to determining drug response phenotypes in cardiovascular disease'20127,947,453'Methods for drug discovery, disease treatment, and diagnosis using metabolomics'20117,910,301'Methods for drug discovery, disease treatment, and diagnosis using metabolomics'20117,682,783'Methods for drug discovery, disease treatment, and diagnosis using metabolomics'20107,682,784'Methods for drug discovery disease treatment, and diagnosis using metabolomics'20107,635,556'Methods for drug discovery, disease treatment, and diagnosis using metabolomics'20097,556,935'Induction of apoptosis by cellular stress'20097,553,616'Methods for drug discovery, disease treatment, and diagnosis using metabolomics'20097,550,260'Methods for drug discovery, disease treatment, and diagnosis using metabolomics'20097,550,258'Methods for drug discovery, disease treatment, and diagnosis using metabolomics'20097,329,489'Methods for drug discovery, disease treatment, and diagnosis using metabolomics'20087,285,573'Use of creatine or creatine analogs for the treatment of diseases of the nervous system'20077,186,754'Use of creatine or creatine compounds for skin preservation'20077,118,862'Induction of apoptosis by cellular stress'20067,005,255'Methods for drug discovery, disease treatment, and diagnosis using metabolomics'20066,720,188'Methods and kits for the detection of arginine compounds'20046,706,764'Use of creatine or creatine analogs for the treatment of diseases of the nervous system'20046,566,086'Diagnostic kit for detecting creatine levels'20036,288,124'Methods of inhibiting undesirable cell growth using an aminoguanidine compound'20016,242,491'Use of creatine or creatine compounds for skin preservation'20016,169,115'Use of aminoguanidine analogs for the treatment of diseases of the nervous system'20016,075,031'Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders'20005,998,457'Creatine analogues for treatment of obesity'19995,676,978'Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent'19975,324,731'Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated'19945,321,030'Creatine analogs having antiviral activity'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994–1997Patents assigned to AMIRA INC (3)· patent assignee history
1994Based in Watertown, MA, US· patent location history
1997–2009Patents assigned to DANA FARBER CANCER INST INC (3)· patent assignee history
1997–2014Based in Belmont, MA, US· patent location history
1999–2007Patents assigned to AVICENA GROUP INC (4)· patent assignee history
2006–2011Patents assigned to CORNELL RES FOUNDATION INC (10)· patent assignee history
2008–2013Patents assigned to METABOLON INC (10)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CORNELL RES FOUNDATION INC | 10 | 2006–2011 |
| METABOLON INC | 10 | 2008–2013 |
| AVICENA GROUP INC | 4 | 1999–2007 |
| AMIRA INC | 3 | 1994–1997 |
| DANA FARBER CANCER INST INC | 3 | 1997–2009 |
Locations
| Location | Patents | Span |
|---|---|---|
| Belmont, Massachusetts, US | 26 | 1997–2014 |
| Watertown, Massachusetts, US | 2 | 1994 |